CT-guided Lung Biopsy Risk Optimization Method
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-100
SponsorInsel Gruppe AG, University Hospital Bern
About this trial
The purpose of this randomized controlled study is to evaluate the extent to which injection of a small amount of fluid in the pleural cavity at the biopsy site may reduce the risk of pneumothoraces, in addition to patient positioning to allow biopsy in gravity-dependent areas of the lung.
Eligibility criteria
Qualifiers
Ability to provide informed consent (knowledge of project languages), >18 years.
Indeterminate or suspicious lung lesion unsuitable for transbronchial biopsy or Status after unsuccessful transbronchial biopsy
Indication for biopsy given by referring specialist (in patients).
Disqualifiers
Preintervention bleeding into the pleural cavity
More than 1 lesion should be biopsied at the same time
Infiltration of the thoracic wall
Pregnancy
Trial design
Treatments tested in this trial
- Fluid application during ct-guided lung biopsy
Treatment groups
198 Participants
are divided into 2 treatment groupsLocations
1Inselspital, Bern University Hospital, University of Bern, Freiburgstrasse 103010, Bern Switzerland
Sponsors and collaborators
Insel Gruppe AG, University Hospital Bern
Lead sponsor
Source ClinicalTrials.gov